Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $2.90 is 50.26% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 2.91||$ 5.60|
|Low:||$ 2.8501||$ 1.93|
Company Description (as filed with the SEC)
We are a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Twirla and our other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. Our lead product candidate, Twirla®, also known as AG200-15, is a once-weekly prescription combination hormonal contraceptive patch that is at the end of Phase 3 clinical development. We completed the third of three Phase 3 clinical trials for Twirla in December 2016 and resubmitted our new drug application, or NDA, which was received by the U.S. Food and Drug Administration, or FDA, on June 26, 2017 and acknowledged as a complete response for FDA review on July 27, 2017. In connection with the NDA resubmission, we were assigned Prescription Drug User Fee Act, or PDUFA, goal date of December 26, 2017 by the FDA. ... More ...
Nasdaq Official Price
Apr. 19, 2018
Apr. 19, 2018